Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Kellerer, M., et al., Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial
The prevalence of atopic diseases has reached epidemic proportions in the 21 st century, which is why the role of oxidative, nitrosative and carbonyl stress in selected atopic diseases should be carefully scrutinized
Injectable B12 bypasses the digestive system, providing more reliable systemic delivery than oral supplementation
Section 3(d) of the Indian Patents Act limits patents on new forms of known substances unless they show significantly enhanced efficacy
You were harmed by a drug that its manufacturer said was safe to take, but research and evidence are quickly proving this isnt true for many patients
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
